Atıf Formatları
Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. B. Türkoğlu Şen Et Al. , "Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma ," 6th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, pp.95, 2017

Türkoğlu Şen, E. B. Et Al. 2017. Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma . 6th International Congress on Leukemia Lymphoma Myeloma , (Antalya, Turkey), 95.

Türkoğlu Şen, E. B., Salim, O., & Ündar, L., (2017). Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma . 6th International Congress on Leukemia Lymphoma Myeloma (pp.95). Antalya, Turkey

Türkoğlu Şen, ELİF, Ozan Salim, And Levent Ündar. "Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma ," 6th International Congress on Leukemia Lymphoma Myeloma, Antalya, Turkey, 2017

Türkoğlu Şen, ELİF B. Et Al. "Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma ." 6th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, pp.95, 2017

Türkoğlu Şen, E. B. Salim, O. And Ündar, L. (2017) . "Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma ." 6th International Congress on Leukemia Lymphoma Myeloma , Antalya, Turkey, p.95.

@conferencepaper{conferencepaper, author={ELİF BETÜL TÜRKOĞLU ŞEN Et Al. }, title={Combination intravitreal rituximab and methotrexate for vitreoretinal lymphoma }, congress name={6th International Congress on Leukemia Lymphoma Myeloma}, city={Antalya}, country={Turkey}, year={2017}, pages={95} }